MetaCap

MiMedx Group (MDXG) vs SS Innovations International (SSII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

MiMedx Group (MDXG) has outperformed SS Innovations International (SSII) over the past year, losing 32.5% versus a loss of 60.9%. MiMedx Group is the larger company by market cap ($681.5 million vs $529.0 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MDXG-33.24%SSII-63.57%
+43%-13%-69%
Oct 9, 20251 yearOct 8, 2026
MDXG-27.03%SSII-29.87%
+217%+56%-106%
Aug 5, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MDXG versus SSII key metrics
MetricMDXGSSII
Share price$4.67$2.65
Market cap$681.51M$529.00M
1-day change+1.08%-0.56%
YTD return-31.02%-53.70%
1-year return-32.51%-60.89%
5-year return-30.92%—
P/E ratio (TTM)116.75—
Forward P/E23.35—
EPS (TTM)$0.04$-0.06
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$7.97$10.00
52-week low$3.03$2.57
Distance from 52-week high-41.41%-73.55%
Analyst consensusnonenone
Avg. price target upside+58.46%+164.65%
Average volume1.23M63.49K
Shares outstanding145.93M200.00M
Employees808483
SectorHealthcareHealth Care
IndustryBiotechnologyMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MDXG has outperformed SSII by 28.4 percentage points over the past year.
  • The two companies sit in different sectors: MiMedx Group in Healthcare and SS Innovations International in Health Care.

About MiMedx Group

MDXG stock →

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.

Healthcare · Biotechnology · 808 employees

About SS Innovations International

SSII stock →

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.

Health Care · Medical/Dental Instruments · 483 employees

MDXG vs SSII FAQ

Which is bigger, MiMedx Group or SS Innovations International?

MiMedx Group (MDXG) is larger, with a market capitalization of $681.51M compared with $529.00M for SS Innovations International (SSII).

Which stock has performed better over the past year, MDXG or SSII?

MDXG returned -32.51% over the past 12 months, compared with -60.89% for SSII (price return, excluding dividends). Past performance does not predict future results.

Are MiMedx Group and SS Innovations International in the same industry?

No. MiMedx Group is in the Healthcare sector, while SS Innovations International is in Health Care.

More comparisons